Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

E.D. Tex.

Allergan, Inc. v. Sandoz, Inc. et al, No. 2:12-cv-00207 (E.D. Tex. Mar. 25, 2013)

Denied
Court
U.S. District Court for the Eastern District of Texas, Marshall Division
Case No.
No. 2:12-cv-00207, Dkt. No. 94
Decided
March 25, 2013
Judge
Rodney Gilstrap, J.
Document
Memorandum Opinion and Order
Length
4 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Before the Court is Defendants’ Motion to Stay Proceedings. (Dkt. No. 42.) Since filing this Motion, Sandoz Inc., Alcon Laboratorie s, Inc., Alcon Research, Ltd., and Falcon Pharmaceuticals, Ltd. have expressly withdrawn their support of the Motion to Stay. (See Dkt. No. 93). Apotex, Inc., Apotex Corp., and Watson Laboratories, Inc. continue to support and wage this Motion. After considering the partie s’ written submissions, the Court DENIES Defendants’ Motion. II. Facts This is a Hatch-Waxman case involving U. S. Patent No.